Stem Cell Meeting on the Mesa Highlights San Diego Synergies
All of the talks and panels are now streaming from Calit2's Multimedia archive. To watch the individual videos, click on the image or video link [Real player and broadband connection required]. Click on speaker names for bios.
Director, UC San Diego Stem Cell Program
Professor, Cellular & Molecular Medicine, UCSD
Length: 1:30 [video]
Chair: Lawrence Goldstein, UCSD School of Medicine
Deconstructing Vertebrate Regeneration
Salk Institute for Biological Studies
Length: 13:59 [video]
Chair: Evan Snyder, Burnham Institute
Chemical and Functional Genomic Approaches Toward Regeneration
The Scripps Research Institute
Length: 12:43 [video]
Beyond Networks: Integrative Collaborative Cyberinfrastructure
UCSD School of Medicine
Length: 18:38 [video]
Round Table Discussion
(l-r) Roger Bingham, Salk Institute (Moderator); State Senator Christine Kehoe; Zach Hall and Robert Klein of the California Institute for Regenerative Medicine; John Moores, JMI; Malin Burnham, Burnham Companies.
Length: 52:00 [video]
|Clinical and Ethical Perspectives
Chair: Michael Kalichman, UCSD Research Ethics Program
|IVF in Intended Parents and Egg Donors: What Does This Mean?
La Jolla IVF
Length: 14:16 [video]
|Clinical and Ethical Perspectives III
Mary Devereaux, UCSD Research Ethics Program (then Q&A with David Smotrich, Barbara Bigby)
Length: 39:15 [video]
|Panel Discussion: The Business of Stem Cells and Startups
Joydeep Goswami , Invitrogen (Moderator); Alan Lewis, CEO, Novocell, Inc.;Joseph Panetta, CEO, BIOCOM;Mark Saad, CFO, Cytori Therapeutics; Zuzana Hostomska, VP, Discovery Biology, Pfizer Global R&D.
Length: 1:17:22 [video ]
In March 2006, UCSD, Salk, Burnham and TSRI announced their commitment to join forces in establishing an independent, non-profit consortium dedicated to stem cell research.
Their joint San Diego Consortium for Regenerative Medicine is establishing a jointly operated facility dedicated to stem cell research, while pursuing funding to support collaborative projects. The Consortium followed the passage in 2004 of Proposition 71. The initiative set aside $3 billion for the formation of the California Institute for Regenerative Medicine (CIRM) to support stem cell research in California.
Major research centers throughout the state are gearing up to participate in this endeavor, pending the resolution of lawsuits challenging the initiative.